Gene therapy for pediatric hearing loss
09-10, 14:00–14:30 (Europe/Istanbul), Pediatric Otolaryngology 2

<p>12- Gene therapy for pediatric hearing loss</p>
<p></p>
Speaker Speaker
<p>Hospital Practitioner, ENT and Head and Neck Surgery, Otology, Children's Audiology</p> <p>Head of the Ped. Audiophonology and Cochlear Implant Unit - Necker-Enfants malades Hospital, Paris</p> <p>Member of the UMRS 1120 Unit, and of the Center for Rare Diseases-Genetic Deafness</p> <p>Career</p> <p>1999--: MD PHD, ENT and Head and Neck Surgery, Armand-Trousseau Children's Hospital, and at Necker-Enfants malades Paris, since 2012</p> <p>2003---: Head of the Pediatric Audiophonology and Cochlear Implant Department, in Armand-Trousseau Children's Hospital and in Necker Enfants malades</p> <p>2020---: Head of the Audiology Research Platform at Necker</p> <p>2022-2024: President of the French Association of Pediatric ENT (AFOP)</p> <p>2024---: Board member - French Society of Audiology</p> <p>Academic activities</p> <p>Head of the Pediatric Audiophonology and Cochlear Implant Uni</p> <p>Head of the Audiology Research Platform at Necker</p> <p>Otologic surgery, cochlear implant surgery</p> <p>Major grants</p> <p>· 2008-2009: National PHRC co-investigator: study on the cost of cochlear implants in France.</p> <p>· 2015-2019: Principal Investigator for Bi-center clinical study: CNRS APHP – Analysis of the development of temporal areas by fNIRS</p> <p>· 2017-2019: ISLODA Co-Investigator: Bi-center study (PHRIC) – Impact of the use of LENA in the rehabilitation of the implanted child</p> <p>· 2017-2021: WP1 RHU- Light4Death (Research on Deaf Patients with Usher Syndrome)</p> <p>· 2019-2025: RHU4 Project Manager - Audinnove</p> <p>· 2025-2027: Project leader and principal investigator PHRC Asymic ped</p> <p>· 2024- : Scientific Lead and Principal Investigator - Audiogene- Gene Therapy Study</p> <p>Conference organization</p> <p>OTOFORUM 2027, Paris, France</p>
This speaker also appears in: